Articles tagged "Kidney transplantation"

2018 American Transplant Congress
Cognitive Impairment Influences Transplant Eligibility
A. Gupta, J. Klein, J. Mahnken, R. Montgomery, A. Ilahe, P. Budhiraja, T. Thomas, T. Schmitt, J. Burns, D. Cibrik.
University of Kansas Medical Center, Kansas City.
Background: Cognitive impairment is common in end stage renal disease and affects health outcomes. Cognitive impairment after solid organ transplants affects medication adherence and graft…
2018 American Transplant Congress
The Impact of the Influenza Vaccine on Pediatric Kidney Transplant Outcomes
M. Camerino,¹ S. Jackson,² S. Chinnakotla,³ P. Verghese.¹
¹Department of Pediatrics, University of Minnesota, Minneapolis, MN; ²Fairview Health Services, Minneapolis, MN; ³Department of Surgery, University of Minnesota, Minneapolis, MN.
The influenza vaccine has been associated with de novo DSA and rejection in adult kidney recipients. This risk has not been adequately assessed in pediatric…
2018 American Transplant Congress
Recurrence of Focal Segmental Glomerulosclerosis (FSGS) and Response to Prolonged Plasmapheresis Therapy: A Single Center Pediatric Experience
A. Bobrowski, D. Matossian.
Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern Feinberg School of Medicine, Chicago, IL.
FSGS is the most common glomerular cause of ESKD in pediatric patients. The risk of recurrence after kidney transplant (KT) is 30-60%, and half of…
2018 American Transplant Congress
Pediatric Transplantation within the ASTS: A Member Survey
W. Andrews, S. Chinnakotla, J. Nathan, A. Gallo, P. Healey, J. Dominique, C. Esquivel.
ASTS, Pediatric Transplant Task Force, Arlington, VA.
Pediatric transplantation has always been a subset of transplants that are performed by members of the American Society of Transplant Surgeons (ASTS). The ASTS formed…
2018 American Transplant Congress
FSGS Pattern with Podocyte Proliferation and Heavy Proteinuria Combined Late Antibody Mediated Rejection of Renal Allograft: Collapsing Glomerulopathy or Transplant Podocytopathy?
J. Wen, M. Zhang, F. Xu, J. Chen, D. Cheng, X. Ni, X. Li.
National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing, Jiangsu, China.
Background: Collapsing Glomerulopathy is a pathologically and clinically distinct variant of FSGS with poor prognosis.Hemodynamic disturbances may play a role in the development of the…
2018 American Transplant Congress
Donor Plasma Mitochondrial DNA Predicts Post-Transplant Renal Allograft Outcomes
F. Han,¹ S. Wan,² N. Chen,² L. Zheng,³ N. Zhang,⁴ Q. Sun,¹ H. Li,¹ Z. Huang,¹ L. Hong,¹ Q. Sun.¹
¹Kidney Transplantation, Sun Yat-sen University, Guangzhou, China; ²Laboratory of Cancer Biomarkers and Liquid Biopsy, Henan University, Henan, China; ³Department of Medical Statistics and Epidemiology, Sun Yat-sen University, Guangzhou, China; ⁴Department of Pathology, Sun Yat-sen University, Sun Yat-sen, China.
The lack of an accurate biomarker makes it difficult to determine whether an organ is acceptable for transplantation. Mitochondrial DNA (mtDNA) correlates with tissue damage…
2018 American Transplant Congress
Effect of De Novo Use of Everolimus with Reduced Calcineurin Inhibitor versus Standard Mycophenolic Acid-Based Regimen on Wound Healing Events in Kidney Transplant Recipients from TRANSFORM Study
M. Henry, F. Citterio, M. Kim, D. Kim, P. Bernhardt, A. Gupta, Y. Watarai.
TRANSFORM Study Group, Novartis Pharma AG, Basel, Switzerland.
Purpose: Anti-proliferative properties of mammalian target of rapamycin inhibitors (mTORi) may affect the wound healing process and there are some reservations about including mTORi into…
2018 American Transplant Congress
Long Term Outcomes of a Steroid Free, Low Dose Tacrolimus with Everolimus Regimen in Kidney Transplant
Y. Kassis,¹ S. Park,¹ A. Shetty,¹ J. Leventhal,¹ V. Mas,² L. Gallon.¹
¹Comprehensive Transplant Center, Northwestern University, Chicago, IL; ²Department of Surgery, University of Virginia, Charlottesville, VA.
Tacrolimus (Tac) is the most effective immunosuppressive agent to prevent acute allograft rejection. However, long-term transplant (Tx) outcomes are limited, at least in part, by…
2018 American Transplant Congress
Opting out and Offers of 'Alibis' for Potential Living Kidney Donors in the US
R. Iskander,¹ S. Kulkarni,² C. Thiessen.²
¹McMaster University, Hamilton, ON, Canada; ²Yale University School of Medicine, New Haven, CT.
Purpose: To delineate rates of and reasons for opting out of living kidney donation, to determine if and how transplant centers offer alibis, to assess…
2018 American Transplant Congress
The New Crescentic Incision: A Good Option for Donor Nephrectomy
M. Haberal,¹ M. Kirnap,¹ A. Akdur,¹ E. Ayvazoglu Soy,¹ S. Yildirim,¹ G. Moray,¹ Z. Kayhan,² A. Torgay.²
¹Transplantation, Baskent University, Ankara, Turkey; ²Anesthesiology, Baskent University, Ankara, Turkey.
Introduction: Living kidney donation helps to avoid or reduce the time period of dialysis and time spent on waiting lists for patients requiring a new…